Today, we live in an “Age of With” where it is not a survival competition against AI but rather a collaboration to elevate human endeavors. AI has generated considerable buzz in the pharmaceutical sector over the past years, and the recent surge in interest around generative AI (ChatGPT) is intensifying discussions even further. Presently, there exists a divergence in perspectives, with some expressing enthusiasm for its potential, while others exhibit caution—this divergence is normal and quite expected. After all, AI have been supporting various sectors in the pharmaceutical world differently.
AI Transforming the Pharmaceutical Industry
The pharmaceutical industry is witnessing the steady integration of artificial intelligence (AI) across various domains, including
Council Post: Amplifying Pharmaceuticals with AI: Unleashing Precision from Molecule to Medicine
- By 理想
- Published on
AI and machine learning continue to drive innovation in drug discovery, manufacturing, and personalized treatments. As these AI tools become more accessible and interpretable over the years, they will become part of the natural process within the pharmaceutical industry.
